XML 16 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2
Consolidated Statements of Comprehensive Loss - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Net loss $ (7,287,605) $ (11,392,857) $ (27,220,171) $ (47,782,363)
Available for sale securities - net unrealized (loss) gain 0 (988) (486) (451)
Total other comprehensive loss 0 (988) (486) (451)
Comprehensive loss (7,287,605) (11,393,845) (27,220,657) (47,782,814)
Comprehensive loss attributable to noncontrolling interests (405,072) (16,908) (522,005) (93,257)
Comprehensive loss attributable to Caladrius Biosciences, Inc. common stockholders $ (6,882,533) $ (11,376,937) $ (26,698,652) $ (47,689,557)